...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Systematic Reviews >Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol
【24h】

Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol

机译：连续葡萄糖监测系统（CGMS）和自我监测血糖（SMBG）与2型糖尿病的血糖（SMBG）的比较：系统审查议定书

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Continuous glucose monitorings (CGMs) have been used to manage diabetes with reasonable glucose control amongst patients with type 2 diabetes (T2D) in recent decades. CGMs measure interstitial fluid glucose levels to provide information about glucose levels, which identify fluctuation that would not have been identified with conventional self-monitoring. Self-monitoring of blood glucose (SMBG) is a classical tool to measure glycaemic changes. However, the effectiveness of glucose control, hypoglycemia, weight change, quality of life and user satisfaction, are needed to evaluate and compare CGMs and SMBG amongst adults with T2D. The review will compare the various forms of CGM systems (i.e flash CGM, real-time CGM, retrospective CGM) versus SMBG or usual intervention regarding diabetes management amongst adults with T2D. The following databases will be searched: Cochrane Library, PubMed, EMBASE, CINAHL, PsycINFO, Scopus and grey literature (ClinicalTrials.gov, PsycEXTRA, ProQuest Dissertations, Google Scholar and Theses Global) for the identification of studies. The studies involving adults (aged ≥ 18?years old) will be included. We will only include and summarise randomised clinical trials (RCTs) with respect to authors, publication type, year, status and type of devices. Studies published in English between February 2010 and March 2020, will be included as the field of CGMs amongst T2D patients has emerged over the last decade. Primary outcomes will be HbA1c (glycosylated haemoglobin level) (mmol/L), body weight (kg), time spent with hypoglycaemia ( 70?mg/dl) or hyperglycaemia (≥ 180?mg/dl), blood pressure ( 140/90?mmHg is considered as good management) and quality of life (understanding and feeling of living situation based on culture and value system). Secondary outcome measures will be user satisfaction (patient or treatment/intervention satisfaction or satisfaction scale) and barriers (physical and mental difficulties or issues). Study selection, data extraction and risk of bias assessment will be conducted independently by at least two reviewers. A third reviewer will determine and resolve discrepancies. Moreover, the quality of the evidence of the review will be assessed according to the Grading of Recommendations Assessment, Development and Evaluation tool (GRADE). The review will synthesise evidence on the comparison between using CGMs and SMBG. The results will support researchers and health professionals to determine the most effective methods/technologies in the overall diabetes management.
机译：连续葡萄糖监测（CGMS）已被用于在近几十年中患有2型糖尿病（T2D）的糖尿病具有合理的葡萄糖对照。 CGMS测量间质血液葡萄糖水平以提供有关葡萄糖水平的信息，该信息识别不具有传统自我监测的波动。血糖（SMBG）的自我监测是一种测量血糖变化的古典工具。然而，需要葡萄糖对照，低血糖，体重变化，生活质量和用户满意度的有效性来评估和比较T2D的成年人中的CGM和SMBG。审查将比较各种形式的CGM系统（即闪存CGM，实时CGM，回顾性CGM）与T2D的成年人中的糖尿病管理的SMBG或通常干预。将搜索以下数据库：Cochrane Library，PubMed，Embase，Cinahl，Psycinfo，Scopus和灰色文学（Clinicaltrials.gov，Psycextra，Proquest论文，Google Scholar和Cheses Globals），用于确定研究。将包括涉及成年人的研究（≥18岁）。我们将仅包括和总结随机化的临床试验（RCT）以及设备的作者，出版类型，年，状态和类型。 2010年2月至2020年3月在英语之间发表的研究将被列为在过去十年中出现的CGMS领域。主要结果将是HBA1C（糖基化血红蛋白水平）（MMOL / L），体重（kg），用低血糖（<70×mg / dl）或高血糖（≥180×mg / dl），血压（<140 / 90？MMHG被认为是良好的管理人物和生活质量（基于文化和价值体系的理解和生活状况）。次要结果措施将是用户满意度（患者或治疗/干预满足或满意度）和障碍（身心困难或问题）。学习选择，数据提取和偏见评估的风险将独立于至少两位审稿人进行。第三次审阅者将确定并解决差异。此外，审查证据的质量将根据建议评估，发展和评估工具（等级）的评分进行评估。审查将综合关于使用CGMS和SMBG之间的比较的证据。结果将支持研究人员和卫生专业人员，以确定整体糖尿病管理中最有效的方法/技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号